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1. Introduction about herbal plants 
Herbs are staging a comeback and herbal ‘renaissance’ is happening all over the globe. 
The herbal products today symbolize safety in contrast to the synthetics that were regarded as 
unsafe to human and environment. Although herbs had been priced for their medicinal, 
flavoring and aromatic qualities for centuries, the synthetic products of the modern age 
surpassed the importance, for a while. However, the blind dependence on the synthetics is over 
and people started returning to the naturals with hope of safety and security. Over the three-
quarters of world population relies mainly on plants and plant extracts for health care. More 
than 30% of the entire plant species, at one time or other was used for medicinal purposes. It 
is estimated that world market for plant derived drugs may account for about Rs.2,00,000 crore. 
It has been estimated that in developed countries like United States, plant drugs constitute as 
much as 25% of the total drugs, while in fast developing countries such as China, India and 
Bangladesh, the contribution is as much as 80%. Thus, the economic importance of medicinal 
plants is much more to countries such as India, Bangladesh than to rest of the world. These 
countries provide two third of the plants used in modern system of medicine and the health 
care system of rural population depend on indigenous systems of medicine. Of the 2, 50,000 
higher plant species on earth, more than 80,000 are medicinal. The drugs are derived either 
from the whole plant or from different organs, like leaves, stem, bark, root, flower, seed, etc. 
Some drugs are prepared from excretory plant product such as gum, resins and latex. Even the 
Allopathic system of medicine has also adopted a number of plant-derived drugs which form 
an important segment of modern pharmacopoeia. Some important chemical intermediates 
needed for manufacturing the modern drugs are also obtained from plants (Eg. diosgenin, 
solasodine, b-ionone). Not only, that plant-derived drug offers a stable market worldwide, but 
the plants aslo continue to be an important source for new drugs. Traditional systems of 
medicine continue to be widely practiced on many accounts. Population rise, inadequate supply 
of drugs, prohibitive cost of treatments, side effects of several allopathic drugs and 
development of resistance to currently used drugs for infectious diseases have led to increased 
emphasis on the use of plant materials as a source of medicines for a wide variety of human 
ailments. Global estimates indicate that 80% of about 4 billion population cannot afford the 
products of the Western Pharmaceutical Industry and have to rely upon the use of traditional 
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medicines which are mainly derived from plant material. This fact is well documented in the 
inventory of medicinal plants, listing over 20,000 species. In spite of the overwhelming 
influences and our dependence on modern medicine and tremendous advances in synthetic 
drugs, a large segment of the world population still likes drugs from plants. In many of the 
developing countries the use of plant drugs is increasing because modern life saving drugs are 
beyond the reach of three quarters of the third world’s population although many such countries 
spend 40-50% of their total wealth on drugs and health care. As a part of the strategy to reduce 
the financial burden on developing countries, it is obvious that an increased use of plant drugs 
will be followed in the future 1. 
1.1 Introduction to Traditional plant medicine 
For thousands of years plants and their derivatives are being used for the treatment of 
diabetes. A large number of animal studies to test the claimed activity have demonstrated the 
anti-hyperglycemic property of many of these plants. In addition, clinical trials have shown 
some plants as useful anti-diabetic agents, but the pure chemical compounds isolated from the 
crude extracts of these plants neither bear structural resemblance to the anti-diabetic drugs in 
current clinical use nor have similar mechanisms of action. But still the search for a novel anti 
diabetic drug advocates the utilization of plants as a potential source and can be achieved by 
application of modern scientific technology and recent knowledge on the physiological 
changes in case of diabetes2. 
Traditional plant medicines are herbal formulations, which might offer a natural key to 
unlock diabetic complications. Medicinal plants plays an important role in the management of 
diabetes mellitus especially in developing countries where the resources are meager. Medicinal 
plants used to treat anti hyperglycemic conditions are of considerable interest for ethno-
botanical community as they are recognized to contain valuable medicinal properties in 
different parts of the plant and a number of plants have shown varying degree of anti-
hyperglycemic activity3. 
Approximately 80% of population are dependent on traditional therapies for their health 
care and has been sustained by the WHO recommendation to include traditional medicines in 
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the primary health care level of these countries. Most of the traditional therapies were 
constituted of plants. When tested using modern methods of evaluation only 18% were found 
to exhibit some kind of pharmacological activity. According to the review compiled by 
Bnouham et al3., the families of plants with the most potent anti-hyperglycemic effects include: 
Leguminaceae (11 species), Laminaceae (8 species), Lilliaceae (8 species), Cucurbitaceae (7 
species), Asteraceae (6 species), Moraceae (6 species), Rosaceae (6 species), Euphorbiaceae 
(5 species), Araliaceae (5 species).The commonly studied species are: Opuntia streptacantha, 
Trigonella fenumgraeicum L, Momordica charantia L, Ficus bengalensis L, Polygala senega 
L, and Gymnema sylvestra R6.  
The traditional medicine all over the world in now a days revalued by an extensive 
activity of research on different plant species and their therapeutic principles. Numerous 
physiological and chemical processes in the human body may produce oxygen centered free 
radicals and other reactive oxygen species as byproducts. Over production of such free radicals 
can cause oxidative damage to biomolecules (ex: lipids, proteins, DNA), which leads to many 
chronic diseases such as atherosclerosis, cancer, diabetes, aging and other degenerative 
diseases in humans. Plants (fruits, vegetables, medicinal herbs etc.,) may contain a wide variety 
of free radical scavenging molecules2,3,4 such as (phenolic compounds, lignans, stilbenes, 
tannis), nitrogen compounds (alkaloids, amides, betulains), vitamins, terpenoids (including 
carotenoids) and some other endogenous metabolites which are rich in antioxidant activity4,5. 
The intake of natural antioxidants have been associated with reduced risk of cancer, cardio 
vascular diseases, diabetes and other diseases associated with aging. 
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2. Introduction     
Diabetes represents a spectrum of metabolic disorders, which has become a major health 
challenge worldwide7. The unprecedented economic development and rapid urbanization in 
Asian countries, particularly in India has led to a shift in health problems from communicable 
to non-communicable diseases. Of all the non-communicable diseases, diabetes and 
cardiovascular diseases lead the list. Diabetes is pandemic in both developed and developing 
countries. The greatest relative rise is predicted in the developing countries of the Middle 
Eastern Crescent, Subsaharan Africa and the Indian subcontinent. By the year 2030, over 85 
percent of the world’s diabetic patients will be in developing countries. In India alone, the 
prevalence of diabetes is expected to increase from 31.7 million in 2000 to 79.4 million in 20308. 
These estimates are valid only if the prevalence of obesity remains the same. Since the incidence 
of obesity is rising at an alarming rate in developed and developing countries, the projections 
for the number of diabetes could well be a gross underestimation. The prevalence of Type 2 
diabetes is 4-6 times higher in the urban areas as compared to rural areas 9. The prevalence of 
impaired glucose tolerance (IGT) in the rural population is also high at 7-8%, which indicates 
presence of a genetic basis for Type 2 diabetes in ethnic Indian population 10. The Diabetes 
Control and Complications Trial (DCCT) demonstrated that good metabolic control, resulting 
from intensive insulin therapy, reduced the risk of progression or development of retinopathy, 
nephropathy and neuropathy in type 1 diabetes 11. The United Kingdom Prospective Diabetes 
Study (UKPDS) showed that intensive glycemic control in type 2 diabetes significantly reduced 
the risk of development and deterioration of microvascular complications 12. The target for good 
glycemic control recommended by the American Diabetes Association (ADA) is glycated 
hemoglobin A1c (HbA1c) <7.0%. The primary goal of the management of diabetes mellitus is 
the attainment of near normal glycemia 13,14. 
 
2.1 Definition 
According to WHO, Diabetes mellitus is defined as a metabolic disorder of multiple 
aetiology characterized by chronic hyperglycemia with disturbances of carbohydrate, protein 
and fat metabolism resulting from defects in insulin secretion, insulin action, or both. The 
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clinical diagnosis of diabetes is often indicated by the presence of symptoms such as polyuria, 
polydipsia, and unexplained weight loss, and is confirmed by measurement of abnormal 
hyperglycemia 15. 
Diabetes mellitus (DM) is the most severe and challenging metabolic pandemic of the 21st 
century. This is because it affects essential biochemical activities in almost every cell in the 
body and increases the risk of cardiac and renal disorders. The worldwide survey reported that 
DM is affecting nearly 10% of the population16. This pandemic is characterized by excessive 
sugar in the blood due to deficiency in production of insulin by the pancreas or by the 
ineffectiveness of the insulin produced to control blood glucose. This disorder affects 
carbohydrate, protein and fat metabolism17, and chronic hyperglycemia causes glycation of 
body proteins that in turn leads to secondary complications that affects eyes, kidneys and 
nerves18.  
 
2.2  Epidemiology 
     The global increase in the prevalence of diabetes is due to population growth, aging, 
urbanization and an increase of obesity and physical inactivity. The primary determinants of the 
epidemic are the rapid epidemiological transition associated with changes in dietary patterns 
and decreased physical activity. Unlike in the West, where older populations are most affected, 
the burden of diabetes in Asian countries is disproportionately high in young to middle aged 
adults results in long lasting adverse effects on a nation’s health and economy, especially for 
developing countries. Healthcare expenditures on diabetes are expected to account for 11.6% of 
the total healthcare expenditure in the world in 2010. Estimated global healthcare expenditures 
to treat and prevent diabetes and its complications are expected to total at least 376 billion U.S. 
Dollars (USD) in 2010. By 2030, this number is projected to exceed some USD 490 billion 19. 
 
     Diabetes is huge and growing problem, and cost to society is high and escalating. In South 
East Asia half of people with diabetes remain undiagnosed. Total deaths due to diabetes was 
12,00,000 out of which 6,80,500 were women , 5,19,500 were men and the 55.1% of the 
population was found to be under the age of 60yrs 20. 
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     According to International Diabetes Federation, the South East Asia at a glance showed that 
the adult population in the age between 20-79yrs who are suffering from diabetes are 883 
millions in 2013 and by 2035 it may raise to 1217 millions and the Regional prevalence is 8.2% 
in 2013 which may increase to 10.1% by 2030, similarly comparative prevalence is 8.7% to 
9.4% in 2013 and 2035 respectively. 
 
     The age between 20-79yrs, Regional prevalence of Impaired Glucose Tolerance in 2013 was 
found to be 2.7% which may increase to 3.2% by 2035, similarly comparative prevalence from 
2.9% to 3%.In between the age of 10-14yrs number of children with type-1 diabetes was found 
to be 7,79,000 in 2013 and newly diagnosed cases per year was 1,25,000.In between the age of 
20-79yrs the number of people with diabetes in 2013 was 72.1 millions by 2035 it will enhance 
to 123.0 millions. The number of people with Impaired Glucose Tolerance in 2013 was 24.3 
millions which may enhance to 38.8 millions. 
 
 
 
  TOP 10 Countries/Territories for number of people with Diabetes (20-79),2015 and 2040 
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      Number of people living with diabetes who are undiagnosed, 2015  
2.3  CLASSIFICATION 
Diabetes Mellitus was merely classified into following types. They are 
 Type-1 Diabetes Mellitus 
 Type-2 Diabetes Mellitus 
 Type-3 Diabetes Mellitus 
 Type-4 Diabetes Mellitus                                         
2.3.1 Type 1 Diabetes Mellitus  
 
     It is also called “Insulin Dependent Diabetes Mellitus” (IDDM) because in such patients, due 
to an absolute lack of insulin, regular injections of insulin are needed to save life. Earlier, it was 
called “juvenile-onset diabetes” because it most commonly develops either before puberty or in 
youngsters below 20years of age and persists throughout their life. IDDM is an autoimmune 
disease of the pancreatic beta cells (type-1A) resulting in their degeneration. It could also be 
idiopathic (type-1B).Viral infection such as echo-virus can also damage pancreatic beta cells 
(type-1B) .Approximately 10% of diabetics suffer with type 1 DM. These patients have a low 
degree of genetic predisposition, yet 15-20% of patients reveal a positive family history and the 
incidence in homozygous twins is about 50%. 
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2.3.2 Type 2 Diabetes Mellitus  
 
This is also called “Non Insulin Dependent Diabetes Mellitus” (NIDDM) or “Maturity 
Onset Diabetes” (as it occurs late in life). Approximately, 90-95% of diabetics have type-2 
diabetes. It usually occurs in people who are over 40 and over weight. Many type-2 diabetics, 
however, have a significant amount are elevated levels of insulin. For these people diabetes 
arises not from shortage of insulin but because their target cells have become relatively 
insensitive to insulin (peripheral resistance to insulin). Genetic predisposition, in type-2 DM, is 
important as there is greater than 94% concordance in identical twins. 
 
2.3.3 Type 3 Diabetes Mellitus  
 
     In this type, there are other causes of hyperglycemia, e.g., chronic pancreatitis or chronic 
drug therapy with glucocorticoids, thiazide diuretics, diazoxide , growth hormone and with 
some protease inhibitors used to treat human immunodeficiency virus infections (e.g., 
saquinavir). 
 
2.3.4 Type 4 Diabetes Mellitus  
 
     It is also called “Gestational Diabetes Mellitus” (GDM). It is observed in approximately 4-
5% of all pregnancies. Elevated blood sugar levels are usually observed in second or last 
trimester of pregnancy and usually resolved during the postpartum period. There is no genetic 
predisposition. The most plausible cause is that during pregnancy, the placental hormones 
promote insulin resistance 21. 
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OVER VIEW OF DM 
 
 
2.4 Etiology 
  
     The two main types of diabetes are type 1 diabetes and type 2 diabetes. A third type, 
gestational diabetes, develops only during pregnancy. Other types of diabetes are caused by 
defects in specific genes, diseases of the pancreas, certain drugs or chemicals, infections, and 
other conditions. Some people show signs of both type 1 and type 2 diabetes 22. 
 
2.4.1 Type 1 Diabetes mellitus 
     Type 1 diabetes is caused by a lack of insulin due to the destruction of insulin producing beta 
cells in the pancreas. In type 1 diabetes an autoimmune disease the body’s immune system 
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attacks and destroys the beta cells. Normally, the immune system protects the body from 
infection by identifying and destroying bacteria, viruses, and other potentially harmful foreign 
substances. But in autoimmune diseases, the immune system attacks the body’s own cells. In 
type 1 diabetes, beta cell destruction may take place over several years, but symptoms of the 
disease usually develop over a short period of time 23. Type 1 diabetes typically occurs in 
children and young adults, though it can appear at any age. In the past, type 1 diabetes was 
called juvenile diabetes or insulin-dependent diabetes mellitus 24. 
     Latent autoimmune diabetes in adults (LADA) may be a slowly developing kind of type 1 
diabetes. Diagnosis usually occurs after age 30. In LADA, as in type 1 diabetes, the body’s 
immune system destroys the beta cells. At the time of diagnosis, people with LADA may still 
produce their own insulin, but eventually most will need insulin shots or an insulin pump to 
control blood glucose levels. Genetic Susceptibility, Autoimmune Destruction of Beta Cells, 
Environmental Factors , Viruses and infections, Infant feeding practices also leads to DM 25.
  
   
Possible mechanism for development of type 1 diabetes. 
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2.4.2 Type 2 Diabetes mellitus 
     Type 2 diabetes the most common form of diabetes is caused by a combination of factors, 
including insulin resistance, a condition in which the body’s muscle, fat, and liver cells do not 
use insulin effectively. Type 2 diabetes develops when the body can no longer produce enough 
insulin to compensate for the impaired ability to use insulin. Symptoms of type 2 diabetes may 
develop gradually and can be subtle; some people with type 2 diabetes remain undiagnosed for 
years. Type 2 diabetes develops most often in middle-aged and older people who are also 
overweight or obese. The disease, once rare in youth, is becoming more common in overweight 
and obese children and adolescents. Scientists think genetic susceptibility and environmental 
factors are the most likely triggers of type 2 diabetes. Genetic Susceptibility , Obesity and 
Physical Inactivity , Insulin Resistance, Abnormal Glucose Production by the Liver ,Metabolic 
Syndrome, Beta Cell Dysfunction can lead to DM 26,27. 
 
2.4.3 Other Types of Diabetes 
     Other types of diabetes have a variety of possible causes. They include Genetic Mutations 
Affecting Beta Cells, Insulin, and Insulin Action , Other Genetic Diseases, Damage to or 
Removal of the Pancreas, Endocrine Diseases, Autoimmune Disorders, Medications and 
Chemical Toxins and Lipodystrophy. 
 
2.5 Pathophysiology 
2.5.1 Type 1 Diabetes mellitus 
     Type-1 DM is an autoimmune disease of the pancreatic beta cells (type-1A) resulting in 
their degeneration. It could also be idiopathic (type-1B).Viral infection such as echo-virus can 
also damage pancreatic beta cells (type-1B). Approximately 10% of diabetics suffer with type-
1 DM. These patients have a low degree of genetic predisposition, yet 15-20% of patients reveal 
a positive family history and the incidence in homozygous twins is about 50%. 
     The clinical features of type-1 DM include hyperglycaemia with polyuria, polydipsia, 
polyphagia and ketoacidosis. These patients are generally not obese.Diabetic ketoacidosis is 
the end result of insulin deficiency in uncontrolled type-1 diabetes 28. 
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Pathophysiology of Type-I Diabetes 
 
Since insulin is not present to aid the entry of glucose in skeletal muscles and body cells, most 
cells now use fatty acids to produce ATP to compensate and to provide calories. This 
accelerated fat breakdown generates Acetyl Co-A. But, due to DM, this acetyl Co-A cannot be 
removed by Kreb`s cycle (to H2O2 and CO2) and therefore gets accumulated. In absence of 
aerobic carbohydrate metabolism, two acetyl Co-A molecules join to form acetoacetic acid, 
beta hydroxyl butyaric acid and acetone, which are collectively called ketone bodies. These 
metabolic products cause metabolic acidosis or diabetic ketoacidosis, which decreases glucose 
utilization in brain and decreases pH of the blood leading to coma and death. Renal loses of 
glucose (glycosuria), nitrogenous substances and ketone bodies (ketoacidosis) promote 
osmotic dieresis (polyuria) that can result in dehydration and thirst (polydipsia) 28. 
 
2.5.2 Type 2 Diabetes mellitus 
     Type 2 diabetes is caused by either inadequate production of the hormone insulin or a lack 
of response to insulin by various cells of the body. In type 2 diabetes, the body either produces 
inadequate amounts of insulin to meet the demands of the body or insulin resistance has 
Evaluation on Anti-Diabetic effect of Ethanolic Extract of Whole plant of Nymphaea pubescens willd on Streptozotocin 
induced Diabetes in Wistar rats 
 
  
DEPARTMENT OF PHARMACOLOGY 13 
 
developed. Insulin resistance refers to when cells of the body such as the muscle, liver and fat 
cells fail to respond to insulin, even when levels are high. In fat cells, triglycerides are instead 
broken down to produce free fatty acids for energy; muscle cells are deprived of an energy 
source and liver cells fail to build up glycogen stores. This also leads to an overall rise in the 
level of glucose in the blood. Glycogen stores become markedly reduced and there is less 
glucose available for release when it may be needed. Obesity and lack of physical activity are 
thought to be major causes of insulin resistance 29. 
 
 
 
 
 
 Pathophysiology of Type-II Diabetes 
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2.6 Diagnosis 
Diabetes mellitus is characterized by recurrent or persistent hyperglycemia, and is 
diagnosed by demonstrating any one of the following:  
 Fasting plasma glucose level ≥ 7.0 mmol/l (126 mg/dl)  
 Plasma glucose ≥ 11.1 mmol/l (200 mg/dL) two hours after a 75 g oral glucose load as in 
a glucose tolerance test. 
 Symptoms of hyperglycemia and casual plasma glucose ≥ 11.1 mmol/l (200 mg/dl)  
 Glycated hemoglobin (Hb A1C) ≥ 6.5%. 
A positive result, in the absence of unequivocal hyperglycemia, should be confirmed by a 
repeat of any of the above methods on a different day. It is preferable to measure a fasting 
glucose level because of the ease of measurement and the considerable time commitment of 
formal glucose tolerance testing, which takes two hours to complete and offers no prognostic 
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advantage over the fasting test. Two fasting glucose measurements above 126 mg/dl (7.0 
mmol/l) is considered diagnostic for diabetes mellitus. 
 
2.7 Signs and symptoms 
Symptoms of type I diabetes 
 Being very thirsty 
 Feeling hungry 
 Feeling tired all the time 
 Having blurry eyesight 
 Feeling numbness or tingling in your feet 
 Losing weight without trying 
 Urinating more often (including urinating at night or bedwetting in children who were 
dry overnight before)30  
Symptoms of type II diabetes 
 Frequent urination 
 Increased thirst 
 Increased hunger 
 Blurred vision 
 Slow-healing wounds or sores 
 Prolonged and unexplained fatigue 
 Numbness or tingling or burning sensation in the legs or feet 
 Gynecological fungal infections in women 
 Sexual impotence in men 
 Muscle cramps 31 
     Symptoms of retinopathy are minimal until advanced disease ensues with loss or blurring 
of vision. Signs of non-proliferative retinopathy include microaneurysms, venous loops, retinal 
hemorrhages, hard exudates, and soft exudates. Proliferative retinopathy can include new 
vessels in the eyes or vitreous hemorrhage. The earliest sign of nephropathy is hypertension. 
Development of hypertension often coincides with the development of microalbuminuria. As 
nephropathy worsens, patients can develop edema, arrhythmias associated with hyperglycemia, 
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and/or symptoms related to renal failure. Signs and symptoms of neuropathy are dependent on 
the type of neuropathy that develops. Most commonly, patients develop symptomatic distal 
polyneuropathy. Signs include depression or loss of ankle jerks and vibratory sensation, with 
hyperalgesia and calf pain in some patients. The deficit is in a stocking glove distribution. 
Wasting of the small muscle of the hands and feet can also occur. Patients may present with 
focal neuropathies due either to mononeuritis or entrapment syndromes. These produce focal 
neurologic deficits confined to a single nerve. A rare but severe form of diabetic neuropathy is 
diabetic amyotrophy, which begins with pain followed by severe weakness and spreads from 
unilateral to bilateral. It resolves spontaneously in 18-24 months. Patients with coronary artery 
disease can present with stable angina pectoris, unstable angina pectoris, or myocardial 
infarction. Many patients have unrecognizable symptoms and can present with dysrhythmias. 
Patients with cerebral vascular disease can present with a sudden onset of a focal neurologic 
deficit such as facial droop, hemiparesis, or isolated weakness of an arm or leg. Dizziness, 
slurred speech, gait difficulties, and visual loss can also be presenting symptoms. Stroke 
symptoms that last <24 hours are referred to as atransient ischemic event. Peripheral vascular 
disease is recognized by exertional leg pain that can progress to rest pain and ischemic ulcers. 
Most cases are asymptomatic. 
 
2.8 Risk factors and complications 
     The major cause of the high morbidity and mortality rate associated with diabetes is a group 
of microvascular and macrovascular complications affecting multiple organ systems. People 
with diabetes have a greatly increased risk for blindness, kidney failure, myocardial infarction, 
stroke, necessary limb amputation, and a host of other maladies. The onset and progression of 
these complications is strongly linked to the presence of sustained hyperglycemia. The 
complication rate and the severity of complications increase as the duration of diabetes 
increases. Other disorders (such as hypertension and dyslipidemia) commonly seen in people 
with diabetes increase the risk for microvascular and macrovascular complications. There may 
also be genetic determinants of risk for diabetic complications 32.  
Evaluation on Anti-Diabetic effect of Ethanolic Extract of Whole plant of Nymphaea pubescens willd on Streptozotocin 
induced Diabetes in Wistar rats 
 
  
DEPARTMENT OF PHARMACOLOGY 17 
 
 
  RISK FACTOS AND COMPLICATIONS OF DIABETES 
2.9 Prevention 
     There is no known preventive measure for type 1 diabetes. Type 2 diabetescan often be 
prevented by a person being a normal body weight, physical exercise, and following a healthy 
diet. Dietary changes known to be effective in helping to prevent diabetes include a diet rich in 
whole grains and fiber, and choosing good fats, such as polyunsaturated fats found in nuts, 
vegetable oils, and fish. Limiting sugary beverages and eating less red meat and other sources 
of saturated fat can also help in the prevention of diabetes. Active smoking is also associated 
with an increased risk of diabetes, so smoking cessation can be an important preventive measure 
as well. 
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2.10 Management of diabetes 
The mainstay of non-pharmacological treatment of diabetes is diet and physical activity. 
Other methods of treatment includes acupuncture, hydrotherapy, mineral supplementation and 
conventional drugs which includes exogenous insulin, oral hypoglycemic agents and 
transplantation. 
Oral glucose lowering drugs belong to five classes of oral agents approved for the 
management of diabetes mellitus. Oral therapy was indicated in any patient in whom diet and 
exercise fail to achieve acceptable glycemic control. Although initial response may be good, 
oral hypoglycemic drugs may lose their effectiveness in a significant percentage of patients. 
The drug category includes sulfonylurea, biguanide, α-glucosidase inhibitor, thiazolidinedione 
and meglitinide and these drugs have various side effects. For instance; sulfonylurea causes 
weight gain due to hyperinsulinemia, biguanide cause body weakness, fatigue, lactic acidosis 
and alpha glucosidase inhibitor may cause diarrhea while thiazolidinediones may increase 
LDL-cholesterol level33. Insulin is the commonly included in an oral agent when glucose 
control is sub-optimal at maximal dose of oral medication. Weight gain and hypoglycemia are 
the most common side effects of insulin. Vigorous insulin treatment may also carry an increase 
in atherogenesis34 
 Oral glucose-lowering agent sulfonylurea, tolbutamide and glyburide acts by enhancing 
insulin secretion from the pancreatic β cells35. These act on liver cells stimulating breakdown of 
glucose in glycolytic pathway and inhibiting glucose generation. Sulphonylureas acts by 
inhibiting the KATP channels in plasma membranes of pancreatic β cells. The inhibition works 
to stimulate the secretion of insulin which is similar to that produced by glucose in the body but 
is of a distinct mechanism. They may be used as first-line drugs in a case where oral 
hypoglycemic medication is required particularly in patients who cannot tolerate metformin. 
Newer drugs in this category such as glipizide and glimipramide appear to afford similar 
efficacy than older drugs such as gliclazide36.  
  All sulphonylureas drugs have a sulphonic acid-urea nucleus, and different chemical 
moieties are added at various positions on the nucleus to make different drugs. The action of the 
resultant drugs may have the desired effect, however, the potency and efficacy may differ 
significantly37.  
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  Sulphonylureas drugs are typically not indicated for type 1 diabetic patients since they 
require the functioning of the β cells to produce the desired effect on blood glucose. They have 
been found to be most effective in non-obese patients with mild maturity onset diabetes and 
whose high glucose levels have not responded appropriately to diet alterations.  
  Biguanides such as metformin acts by increasing glucose transport across cell membrane 
of the skeletal muscle. They act in the presence of endogenous insulin, and are effective only 
where there are residual functioning pancreatic islet cells. Metformin is widely used in treatment 
of patients with insulin resistance because it can be used safely as an adjunct to diet therapy in 
obese patients to control their high glucose levels especially those who are not responsive to 
other therapies. The exact mode of action of metformin is disputable. Zhou et al indicated that 
it activates adenosine monophosphate protein kinase (AMPK) in liver cells leading to increased 
fatty acid oxidation and glucose uptake by cells38. An overall reduction in lipogenesis and 
hepatic glucose production is normally observed. Metformin has antioxidant properties which 
are useful in its use in treatment of diabetes and cardiovascular disease. It has been demonstrated 
to inhibit xanthine oxidase and phosphodiesterase, advanced glycation end product formation 
and decreased production of tumour necrosis factor39.  
  The main problem with metformin is the risk of lactic acidosis which is particularly 
common in patients with renal insufficiency, cardiovascular disease, peripheral vascular 
disease, liver disease, pulmonary disease and in individuals over 65 years. Weakness, fatigue, 
shortness of breath, nausea, dizziness and kidney toxicity are the side effects. 
  Thiazolidinediones are known to act by increasing the sensitivity of peripheral tissues to 
insulin by affecting the expression of specific genes. They achieve this by binding and activating 
γ peroxisome proliferator-activated receptor (PPAR-γ), a nuclear receptor. Some of the effects 
of this gene expression include the increase in the expression of the glucose transporters, 
decreased hepartic glucose output as well as the increased differentiation of pre-adipocytes into 
adipocytes. The high affinity of this drug to PPAR-γ is important in the management of insulin 
resistance since large adipocytes that differentiate from smaller ones produce TNF-α which 
increase insulin resistance. Thiazolidinediones therefore suppresses the expression of these 
adipokines involved in insulin resistance40.  
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  Alpha-glucosidase acts by inhibiting alpha glucosidase enzyme in the brush border of 
the small intestine. This delays the absorption of glucose by decreasing the breakdown of 
complex carbohydrates by enteric digestive enzymes. Some of the most commonly used α-
glucosidase inhibitors like acarbose have severe gastrointestinal side effects such as diarrhoea, 
flatulence and abdominal pains. This raises the need for other sources of these inhibitors that 
have fewer side effects. The most obvious choice for these alternatives would be plants with 
ethnomedical uses in management of diabetes.  
 
2.11 Introduction of Streptozotocin 
Streptozotocin is a permanent diabetes inducing drug. It is synthesized by a strain of the 
soil microbe Streptomyces achromogenes (gram positive bacterium) with broad spectrum of 
antibacterial properties. Streptozotocin is an unusual aminoglycoside containing a nitrosoamino 
group discovered in 1959 as an antibiotic, now marketed as a generic drug. The nitrosoamino 
group enables the metabolite to act as a nitric oxide (NO) donor. NO is an important messenger 
molecule involved in many physiological and pathological processes in the body. Streptozotocin 
is widely used to induce diabetes in rodent models by inhibition of β-cell O-GlcNAcase. 
Streptozotocin features four important biological properties as evidenced by its 
antibiotic, β-cell (beta)-cytotoxic, oncolytic, as well as oncogenic effects. This product is an 
antineoplastic antibiotic and is used mainly in the treatment of pancreatic (islet cell) tumors. It 
is used for the treatment of malignant insulinoma. Current use of STZ is mostly as an 
investigational drug for diabetes research due to its specific toxicity associated with pancreatic 
β-cells. Low affinity glucose transporter- GLUT2 of βcells transports STZ into the cell and 
causes alkylation of DNA and irreversible necrosis of β cells. DNA synthesis in mammalian 
and bacterial cells is inhibited by action of STZ. STZ is widely used to induce both insulin-
dependent (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM). STZ is an antibiotic 
and antitumor agent, induces diabetes mellitus via reduction of nicotinamide adenine 
dinucleotide in pancreatic β-cells in vivo. This review will summarize the chemistry of STZ and 
its β-cell toxicity through the link between STZ and free radicals. In addition, dosage, route of 
administration and metabolism of STZ in experimental animal models to study diabetes will be 
addressed41. 
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2.12 Mechanism of action of Streptozotocin 
 
The range of the STZ dose is not as narrow as in the case of alloxan. The frequently used 
single intravenous dose in adult rats to induce IDDM is between 40 and 60 mg/kg b.w., but 
higher doses are also used. STZ is also efficacious after intraperitoneal administration of a 
similar or higher dose, but single dose below 40 mg/kg b.w. may be ineffective . For instance, 
when 50 mg/kg b.w. STZ are injected intravenously to fed rats, blood glucose (determined 2 
weeks after treatment) can reach about 15 mM STZ may also be given in multiple low doses. 
Such treatment is used predominantly in the mouse and the induction of IDDM is mediated by 
the activation of immune mechanisms. Streptozotocin action in B cells is accompanied by 
characteristic alterations in blood insulin and glucose concentrations. Two hours after injection, 
the hyperglycemia is observed with a concomitant drop in blood insulin. About six hours later, 
hypoglycemia occurs with high levels of blood insulin. Finally, hyperglycemia develops and 
blood insulin levels decrease. These changes in blood glucose and insulin concentrations reflect 
abnormalities in B cell function. STZ impairs glucose oxidation and decreases insulin 
biosynthesis and secretion. It was observed that STZ at first abolished the B cell response to 
glucose. Temporary return of responsiveness then appears which is followed by its permanent 
loss and cells are damaged. 
 
STZ is taken up by pancreatic B cells via glucose transporter GLUT2. A reduced 
expression of GLUT2 has been found to prevent the diabetogenic action of STZ. Intracellular 
action of STZ results in changes of DNA in pancreatic B cells comprising its fragmentation 
Recent experiments have proved that the main reason for the STZ-induced B cell death is 
alkylation of DNA. The alkylating activity of STZ is related to its nitrosourea moiety, especially 
at the O6 position of guanine. After STZ injection to rats, different methylated purines were 
found in tissues of these animals. 
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Since STZ is a nitric oxide (NO) donor and NO was found to bring about the destruction 
of pancreatic islet cells, it was proposed that this molecule contributes to STZ-induced DNA 
damage. Pancreatic B cells exposed to STZ manifested changes characteristic for NO action, 
i.e. increased activity of guanylyl cyclase and enhanced formation of cGMP. STZ is, however, 
not a spontaneous nitric oxide donor. This molecule is liberated when STZ is metabolized inside 
cells, but NO synthase is not required for this effect. On the other hand, the lowering of NO 
concentration in pancreatic islet cells by inhibition of the inducible form of nitric oxide synthase 
partially counteracted DNA cleavage induced by STZ. A similar effect can be attained by NO 
scavengers. However, the results of several experiments provide the evidence that NO is not the 
only molecule responsible for the cytotoxic effect of STZ. STZ was found to generate reactive 
oxygen species, which also contribute to DNA fragmentation and evoke other deleterious 
changes in the cells. The formation of superoxide anions results from both STZ action on 
mitochondria and increased activity of xanthine oxidase.It was demonstrated that STZ inhibits 
the Krebs cycle and substantially decreases oxygen consumption by mitochondria. These effects 
strongly limit mitochondrial ATP production and cause depletion of this nucleotide in B cells. 
Restriction of mitochondrial ATP generation is partially mediated by NO. This molecule was 
found to bind to the iron-containing aconitase inhibiting enzyme activity. Augmented ATP 
dephosphorylation increases the supply of substrate for xanthine oxidase (B cells possess high 
activity of this enzyme) and enhances the production of uric acid – the final product of ATP 
degradation. Then, xanthine oxidase catalyses reaction in which the superoxide anion is formed. 
As a result of superoxide anion generation hydrogen peroxide and hydroxyl radicals are formed. 
The inhibition of xanthine oxidase by allopurinol restricts the cytotoxic effect of STZ in vitro. 
Pretreatment of B cells with this inhibitor prevented the STZ-induced decrease of insulin 
secretion. It can be stated that potent alkylating properties of STZ are the main reason of its 
toxicity. However, the synergistic action of both NO and reactive oxygen species may also 
contribute to DNA fragmentation and other deleterious changes caused by STZ. NO and reactive 
oxygen species can act separately or form the highly toxic peroxynitrate (Figure). Therefore, 
intracellular antioxidants or NO scavengers substantially attenuate STZ toxicity. STZ-induced 
DNA damage activates poly ADP ribosylation. This process leads to depletion of cellular 
NAD+, further reduction of the ATP content and subsequent inhibition of insulin synthesis and 
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secretion. The concept of unfavorable consequences of augmented poly ADP-ribosylation as a 
result of STZ action was confirmed by experiments revealing that the inhibition of this process 
prevents the toxicity of this diabetogenic agent. It was found that 3-aminobenzamide, a strong 
inhibitor of poly(ADP-ribose) synthase, protected against the action of STZ in rats, even when 
this substance was administered 45-60 min after STZ. Another inhibitor of poly(ADP-ribose) 
synthase, nicotinamide, which is also scavenging oxygen free radicals, exerted best protection 
when it was administered shortly after STZ. The failure of protective action of nicotinamide 
administered after STZ is probably due to a potent reduction of the cellular ATP content by STZ 
since nicotinamide uptake is ATP-dependent. The protective effect of 3-aminobenzamide and 
nicotinamide was also confirmed in vitro. 
It has been suggested that some inhibitors of poly ADP-ribosylation may also exert a 
protective effect due to their hydroxyl radical scavenging properties. However, in the case of 
STZ, recent investigations in poly(ADP-ribose) polymerasedeficient mice demonstrated that the 
inhibition of poly ADP-ribosylation itself prevents STZ-induced B cell damage and 
hyperglycemia. Thus, it can be stated that the activation of poly ADP-ribosylation is of greater 
importance for the diabetogenicity of STZ than generation of free radicals and DNA damage 
per se. Calcium, which may also induce necrosis, does not seem to play a significant role in the 
necrosis evoked by STZ since calcium channel antagonists do not protect B cells against 
streptozotocin, as they do in the case of alloxan42. 
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The mechanism of streptozotocin (STZ)-induced toxic events in B cells of rat pancreas. 
MIT –mitochondria; XOD – xanthine oxidase. 
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3.1 Description 
Nymphaea pubescens(Nymphaeaceae) large perennial aquatic herb with short, erect, 
roundish, tuberous rhizomes; leasves floating, peltate, sharply sinuate-toothed, flowers large, 
floating, solitary, variable in colour from pure white to deep red; fruits spongy many seeded 
berries, seeds minute, grayish black when dry with longitudinal striations. Nymphaea pubescens 
found throughout the warmer parts of India, in tanks, ponds and ditches. Nymphaea pubescens 
of rhizome is cooling, sweet, bitter and tonic, and is useful in diarrhoea, dysentery, dipsia and 
general debility.The flowers are astringent and cardio tonic. The seeds are sweet, cooling, 
constipating, aphrodisiac, stomachic and restorative. They are useful in vitiated conditions of 
pita, dipsia, diarrhea and dermatopathy43. 
 
 
   Nymphaea pubescens 
 
3.2 Regional and other names 
 
Common name - Hairy water lilly 
Tamil   - Vellambal. Neerambal 
Sanskrit  - Kumuda 
Hindi   - Kokaa 
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Malayalam  - Neerambal 
 
 
3.3 Classification 
 
Kingdom  -  Plantae 
Phylum - Tracheophyta 
Class  - Magnoliopsida 
Order  - Nymphaeales 
Genus  - Nymphaea 
Family  - Nymphaeaceae 
Species - N. pubescens 
 
Nymphaea pubescens is known under a number of different synonyms, the most 
common of which is Nymphaea rubra for the reddish variant known under the commercial name 
Red water lily, which often has also purplish leaves. 
 
3.4 Geographical range 
 
Bangladesh; Cambodia; India; Indonesia; Lao People's Democratic Republic; Malaysia; 
Myanmar; Nepal; Pakistan; Philippines; Sri Lanka; Thailand; Viet Nam 
 
3.5 Habitat and etiology 
 
Plants of this species are found commonly in shallow pools and ponds. The hairy water 
lily is found cultivated and also in the wild. It prefers non-acidic water and does not tolerate 
temperature below 15° C. 
 
 
 
Evaluation on Anti-Diabetic effect of Ethanolic Extract of Whole plant of Nymphaea pubescens willd on Streptozotocin 
induced Diabetes in Wistar rats 
 
  
DEPARTMENT OF PHARMACOLOGY 27 
 
3.6 Ethanomedical uses 
 
Nymphaea pubescenes revealed that the presence of alkaloids, flavonoids, glycosides, 
terpenoids, tannins, phenols, saponins and steroids. The hypoglycaemic effect of Nymphaea 
pubescens tuber was found to be inducing insulin release from pancreatic cells of diabetic. 
Nymphaea pubescens tuber extract can reduce the levels of serum urea and creatinine and 
confirms the protection of vital tissues (Kidney and liver) including the pancreas, thereby 
reducing the causation of diabetes in the experimental animals. Ethanol extract of Nymphaea 
pubescens tuber offers a promising therapeutic value in prevention of diabetes. These effects 
could be mainly attributed to its antioxidant properties as shown by significant quenching 
impact on the extract of lipid peroxidation along with, enhancement of antioxidant defense 
systems in pancreatic tissue. The antioxidative property of Nymphaea pubescens extract 
certainly is due to its chemical constituents. Phytochemical investigations of Nymphaea 
pubescens have demonstrated the presence of flavonoids and phenolic compounds as main 
active ingredients having potent antioxidant activities. Further studies will be needed in future 
to determine the main active ingredient having the beneficial antidiabetic, hypolipidaemic and 
antioxidant effects. Nymphaea pubescens was used as blood purifier and in the treatment of 
jaundice. 
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4. Literature review about the work so far done in the plant Nymphaea 
pubescens (willd) 
 
4.1.1. Inhibitory Effect Of Nymphaea pubescens Willd. Flower Extract On Carrageenan-
Induced Inflammation And Ccl₄-Induced Hepatotoxicity In Rats. 
Nymphaea pubescens Willd. is used as ingredient of ethnic diet and folk medicine in 
South-East Asia. The water (NPW), methanol (NPM) and chloroform (NPC) extracts of N. 
pubescens flowers were investigated for NO·, O₂·⁻ and DPPH radical scavenging and iron 
chelating activities in vitro. NPW was found to be the most potent free radical scavenger 
(EC₅₀<100 μg/mL) whereas NPC did not show EC₅₀ at 500 μg/mL. Therefore, NPW was 
selected for further studies on anti-inflammatory and hepatoprotective activities, using standard 
in vitro and in vivo models. NPW exhibited inhibition of nitrogen radical generation in LPS-
activated macrophages (IC₅₀=75.5 μg/mL) through suppression of iNOS protein, with no 
associated toxicity in the cells. Further, 500 mg/kg of NPW reduced rat paw edema by ~50% 
after 6h of carrageenan administration. Hepatoprotective activity of NPW was also evaluated in 
vivo on CCl4-induced hepatotoxicity model in rats. NPW treatment (500 mg/kg/day for ten 
days) attenuated CCl4-induced increase in serum enzymes, viz. alanine and aspartate 
aminotransferases (ALT and AST) and bilirubin. Also, glutathione and superoxide dismutase 
(SOD)-levels were restored towards normalcy in the liver of CCl4-treated rats, indicating the 
hepatoprotective role of NPW, which was found to contain a fair amount of flavonoids, 
phenolics, and saponin constituents44. 
 
4.1.2. Antiproliferative Activity Of Ethanolic Flower Extract From Nymphaea pubescens 
Willd Against Human Cervical And Breast Carcinoma In Vitro. 
Nymphaea pubescens Willd (Nymphaeaceae) is a fascinating aquatic plant mentioned in 
siddha system of medicine, in the treatment of bleeding piles, diabetes and as cardiotonic in 
palpitation of the heart. Nymphaea species was traditionally used for treating cancer. The 
present study was designed to evaluate the invitro antiproliferative activity of Nymphaea 
pubescens Willd. The ethanolic extract of different parts such as rhizome, leaf, flower and fruit 
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was subjected for MTT assay. The ethanolic extract of flower part was found to be cytotoxic 
against human cervical carcinoma Hela cell lines and human breast carcinoma MCF cell lines. 
The IC50 value of ethanolic flower extract was 91.57μg/ml against Hela cell lines and 99.6μg/ml 
against MCF-7 cell lines. Significant results were observed thereby justifying the use of plant 
in the traditional system of medicine45. 
 
4.1.3. Antihepatotoxic Efficacy Of Nymphaea pubescens (Willd.) On Acetaminophen 
Induced Liver Damage In Male Wistar Rats.  
The antihepatotoxic efficacy of aqueous flower extracts of Nymphaea pubescens(NP) 
and Silymarin were investigated against acetaminophen induced liver damage in rats. 
Acetaminophen at the dose of 3gm/kg body weight orally produced liver damage in rats as 
manifested by the significant rise in serum levels of aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin, cholesterol and decreases the 
protein level compared with control. Oral administration of flower extracts of Nymphaea 
pubescens(100, 200, 400mg/kg) and silymarin (25mg/kg) once daily for 28 days to 
acetaminophen treated rats shows lowered significantly the afore mentioned clinical parameters 
where as protein level increased. The extract alone treated rats did not adversely affect the serum 
biochemical estimation. A significant antihepatotoxic efficacy of Nymphaea pubescens extracts 
was reported46. 
 
4.1.4. Antihyperglycaemic, Antihyperlipidaemic And Antioxidant Assays(In Vivo) Of 
Nymphaea pubescens Leaf Extract. 
The present study was designed to investigate the possible antidiabetic, hypolipidaemic 
and antioxidant effects of methanol extract of Nymphaea pubescens leaves.Diabetes was 
persuaded in albino rats by injecting of alloxan monohydrate .The methanol extract of 
Nymphaea pubescens leaves at a dose of 250mg/kg and 500mg/kg body weight were 
administered at single dose per day to diabetes induced rats for a period of 28 days. The effect 
of methanol extract of Nymphaea pubescens leaves extract on blood glucose(48), glycosylated 
haemoglobin (HbA1C) (3), Alanine aminotransferase (ALT) (38.5) and Aspartate 
aminotransferase (AST) (56) level. serum lipid profile total cholesterol (TC) (56.5), triglyceride 
Evaluation on Anti-Diabetic effect of Ethanolic Extract of Whole plant of Nymphaea pubescens willd on Streptozotocin 
induced Diabetes in Wistar rats 
 
  
DEPARTMENT OF PHARMACOLOGY 30 
 
(TG) (44), low density lipoprotein- cholesterol (LDLC) (10.5), high density lipoprotein- 
cholesterol (HDL-C) (39) and catalase (CAT) (0.51), lipoprotein peroxidation (LPO) (0.134), 
blood reduced glutathione (GSH) (0.169) were measured in the diabetic rats. The methanol 
extracts of Nymphaea pubescens leaves elicited significant (p<0.05) Declines of blood glucose, 
lipid parameters except HDLCholestrol, serum enzymes and significantly increased HDL-C and 
antioxidant. In conclusion, the methanol extract of Nymphaea pubescens leaves offers 
promising antidiabetic and hypolipidaemic effects compared with control drug that may be 
mainly attributed to its potent antioxidant potential. Additional research will be needed in future 
in order to conclude which one of its active components have the main antidiabetic and 
hypolidaemic effects47. 
 
4.1.5. Phytochemical Analysis And Antimicrobial Properties Of Leaf Extracts Of 
Nymphaea pubescens. 
Objective: 
To evaluate the antimicrobial activity of Nymphaea pubescens extracts against some 
bacteria and fungi. The study also investigated the phytochemical constituents of the plant.  
Methods: 
The phytochemical constituents of the dried powdered plant was extracted using; 
Organic solvents (Hexane: petroleum ether, ethyl acetate and methanol). The antimicrobial 
activity of the concentrated extracts was evaluated by determination of the diameter of zone of 
inhibition against both bacteria and fungi using the Agar well diffusion method. 
Results: 
Results of the phytochemical screening revealed the presence of Alkaloids, Terpenoids, 
Steroids, Anthocyanidins, Phenolic compounds and flavonoids and the methanol, ethyl acetate 
extracts were found to be more potent than hexane: petroleum ether extract. 
Conclusions: 
Nymphaea pubescens has broad spectrum antibacterial activity and a potential source of 
new classes of antibiotics that could be useful for possible treatment of gonorrhea, pneumonia, 
urinary tract and some mycotic infections48. 
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4.1.6. Tapping of Aquatic Plant Nymphaea pubescens WILLD. For Synthesis of Silver 
Nanoparticles and Its Antimicrobial Evaluation. 
 
Nymphaea pubescens Willd. is a traditional medicinal plant used in Ayurvedic 
formulation from ancient times. Today biological synthesis of nanoparticles emerges as an eco-
friendly and cost effective approach in the field of nanotechnology. In the present study, we 
report the biosynthesis of silver nanoparticles (SNPs) using plant leaf extract for the reduction 
of aqueous Ag+ ions into Ag0 particles, characterization and its antimicrobial activity on 
clinically isolated microorganisms. Stable silver nanoparticles were formed by treating aqueous 
solution of Ag(NO3)2 with the plant leaf extract. These nanoparticles are monitored by using 
UV -Visible spectroscopy, FTIR, AFM and EDAX analysis for their synthesis confirmation, 
size and shape distribution. Further these nano particles are evaluated for antibacterial activity 
against clinically isolated bacterial pathogens like, Bacillus subtilis, Escherichia coli, Klebsiella 
pneumoniae Proteus vulgaris, Pseudomonas aeruginosa and Staphylococcus aureus. The UV-
Vis spectroscopic shows a broad peak at 404 nm indicates the formation of SNPs. FT-IR studies 
reveals broad peaks at 3336 cm-1 assigned for O-H bond of phenols and 1637 assigned for N-
H bond of primary amines of proteins. AFM studies clearly indicate the particles are spherical 
in shape having the size range from 66 to 91 nm. EDAX spectrum of synthesized nanoparticles 
shows 5.24 weight percentage Ag metal in the reaction mixture indicates the purity of SNPs. 
Further antimicrobial studies on bacterial pathogens shows potential activity indicates the N. 
pubescens is an ideal plant for the synthesis of SNPs and these biologically synthesized SNPs 
have an advantage over conventional antibiotics49. 
 
4.1.7. Invitro Antioxidant And Free Radical Scavenging Activity Of Nymphaea pubescens 
  
In vitro antioxidant effects of the ethanolic extract of whole plant of Nymphaea 
pubescens were investigated in the present study. 1,1-diphenyl-2-picryl hydroxyl (DPPH) 
quenching assay, Hydroxyl Radical Scavenging Activity, Nitric Oxide Scavenging activity 
using established assay procedures were performed for its antioxidant activity. The generation 
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of free radicals DPPH, nitric oxide and hydroxyl radicals were effectively scavenged by the 
ethanolic extract of Nymphaea pubescens . The extract showed strong antioxidant activity in a 
dose dependent manner. The results from the present study clearly indicates that N. pubescens 
scavenges free radicals, ameliorating damage imposed by oxidative stress in different disease 
conditions and act as a novel source of natural antioxidant50. 
 
4.1.8. Potential antidiabetic, hypolipidaemic and Antioxidant effects of Nymphaea 
pubescens extract in alloxan induced diabetic rats. 
  
The present study was designed to investigate the possible antidiabetic, hypolipidaemic 
and antioxidant effects of ethanol extract of Nymphaea pubescens tuber. Diabetes was induced 
in Albino rats by administration of alloxan monohydrate (150 mg/kg, body weight i.p). The 
ethanol extract of Nymphaea pubescens tuber at a dose of 200mg/kg and 500mg/kg body weight 
were administered at single dose per day to diabetes induced rats for a period of 14 days. The 
effect of ethanol extract of Nymphaea pubescens tuber extract on blood glucose, plasma insulin, 
urea creatinine, glycosylated haemoglobin, serum lipid profile (total cholesterol (TC), 
triglyceride (TG), low density lipoprotein-cholesterol (LDL-C), very low density lipoprotein-
cholesterol (VLDL-C), high density lipoprotein-cholesterol (HDL-C)and phospholipids (PL)), 
serum protein, albumin, globulin, serumenzymes (Serum glutamate pyruvate transaminases 
(SGPT), serum glutamate oxaloacetate transaminases (SGOT) and alkaline phosphate (ALP)), 
lipoprotein peroxidation (LPO), blood reduced glutathione (GSH), oxidative glutathione 
(GSSG), GSH/GSSG ratio, erythrocytes glutathione reductase (GR), glutathione peroxidase 
(GPX) and glutathione S-transferase (GST) were measured in the diabetic rats. The ethanol 
extracts of Nymphaea pubescens tuber elicited significant (p<0.05) reductions of blood glucose, 
lipid parameters except HDL-C, serum enzymes and significantly increased HDL-C and 
antioxidant. The extract also caused significant increase in plasma insulin (p<0.05) in the 
diabetic rats. In conclusion, ethanol extract of Nymphaea pubescens tuber offers promising 
antidiabetic and hypolipidaemic effects that may be mainly attributed to its potent antioxidant 
potential. Further studies will be needed in future in order to determine which one or more of 
its active constituents have the main antidiabetic and hypolipdaemic effects51. 
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4.1.9. Effect of Nymphaea pubescens Leaf Extract on Growth of Nile Tilapia (Oreochromis 
niloticus) 
 
The use of herbal plants has been conducted for the treatment of various ailments since 
the ancient civilizations, but their uses in fish culture are still limited. Plant-based feed 
supplementation may provide the elements or bioactive compounds that would help to enhance 
fish growth and to improve feed utilization. The aims of this present study were therefore, to 
investigate the use of Nymphaea pubescens leaf extract as a feed additive on survival rate and 
growth performance of Nile tilapia (Oreochromis niloticus). N. pubescens leaves were extracted 
using 70% ethanol. One hundred fingerlings were divided into 5 groups: each consisting of 20 
fish. In a feeding trail of 60 days, Group 1-4, fish were fed diets containing 0, 0.05, 0.1 and 1% 
of N. pubescens leaf extract, respectively. Group 5 received 0.05% of oxytetracycline and served 
as a positive control group. Fish were fed two times a day for 60 days. The animal procedures 
were conducted in accordance with the Institutional Animal Care and Use Committee, Ubon 
Ratchathani Rajabhat University, Thailand. It was found that the N. pubescens leaf extract 
supplementation produced a marked significant increases in weight gain and specific growth 
rate and caused a significant decrease in feed conversion ratio when compared to the control 
diet (P<0.05). In addition, there were no significant changes in the cumulative mortality of the 
fish fed with the plant extract compared to the control and positive control groups (P>0.05). 
Fish health and feeding behavior were the same as the control animals, which suggesting that 
N. pubescens leaf extract had no toxic effect on Nile tilapia. Thus, the results of the present 
study demonstrate that N. pubescens leaves are apparently safe and may be used as a natural 
feed additive in fish diets to enhance fish growth52. 
 
4.1.10. Phytochemical Investigation of Nymphaea pubescens and Study of its Antimicrobial 
Activities. 
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Nymphaea pubescens Wild (Nymphaeaceae) is a fascinating aquatic plant used in 
Bangladesh for the treatment of diabetes, liver disorders, urinary problems, menorrhagia, 
blenorragia; also used as tonic and aphrodisiac. The roots used by the traditional healers of the 
Tripura, Marma and Murong tribes to treat dysuria, urinary tract infections and leucorrhea. Also, 
used for indigestion, heart diseases, stomachaches, cancer, and as anti-hemorrhagic. Due to its 
large traditional use, N. pubescens was the plant of choice of our study. Extraction of Nymphaea 
pubescens leaves (700 g) at room temperature by maceration with methanol yielded 122 g 
(17.43% of dry weight) extracts respectively. The methanol extract of Nymphaea pubescens was 
subjected to Vacuum liquid chromatography and five different fractions were collected using 
five different solvents; Fractions were- n-hexane Fraction- Fraction -1, DCM fraction-Fraction-
2, Ethyl-acetate fraction- Fraction-3, Acetone fraction- Fraction-4 and Methanol fraction- 
Fraction-5. Their weights were Fraction-1=7.38 gm, Fraction-2=3.28 gm, Fraction-3=34.66 gm, 
Fraction-4=79.3 gm and Fraction-5=14.27 gm. Among the five fractions n-hexane fraction and 
Ethyl-acetate fraction were subjected to column chromatography. The n-hexane fraction or 
Fraction-1 and ethyl acetate fraction or Fraction-3 of Nymphaea pubescens were separated by 
open column chromatography with silica gel and the fractions were collected monitoring the 
TLC. Fraction-1-40 yielded a colorless crystal, NPH-40. This compound was UV inactive and 
charring with methanol and H2SO4 (9:1) gave characteristic red color indicating the compound 
is a fatty acid derivative. 1HNMR report of NPH-40 informs that may be this is a mixture of 
four fatty acids and those are myristic acid, palmitic acid, lauric acid and 4-methyl-4-
tetradecenoic acid. Further analysis such as 13CNMR, Mass spectroscopy etc is required for 
definite result. Fraction-3-22 yielded another colorless crystal, NPE-22. This compound was 
also UV inactive and charring with methanol and H2SO4 (9:1) gave characteristic brown color 
indicating the compound is a triterpenoid derivative. 1HNMR report of NPE-22 informs that 
may be this compound is oleanolic acid. Further analysis such as 13CNMR, Mass spectroscopy 
etc is also required here for definite result. According to the literature review done so far in this 
research paper, this is the first time that Oleanolic acid has been isolated from Nymphaea 
pubescens53. 
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4.2 Some of the recent Literature reviews about the anti-diabetic activity 
experimented using various medicinal plants 
 
4.2.1 Tadesse Bekele Tafesse et.al (2017), Antidiabetic Activity And Phytochemical 
Screening Of Extracts Of The Leaves Of Ajuga Remota Benth On Alloxan-Induced Diabetic 
Mice. The aqueous extract (500 mg/kg) showed the highest percentage reduction in blood 
glucose levels and the ability of A. remota extracts in reducing blood glucose levels presumably 
due to the presence of antioxidant constituents such as flavonoids. The effect of the extract 
supported the traditional claim of the plant54. 
 
4.2.2 Muhammad Ajmal Shaha et.al (2017), Α-Glucosidase Inhibitory Effect Of 
Rhinacanthins-Rich Extract From Rhinacanthus Nasutus Leaf And Synergistic Effect In 
Combination With Acarbose. This present study provides the first evidence that RRE containing 
rhinacanthin-C as the major compound, could find application as an α-glucosidase inhibitor55. 
 
4.2.3 Martha Thomson et.al (2016), assessed the Anti-Diabetic And Anti-Oxidant 
Potential Of Aged Garlic Extract (AGE) In Streptozotocin-Induced Diabetic Rats. Treatment 
with AGE positively reversed the diabetic changes in the targeted parameters to levels 
significantly lower than those measured in the CD group and the degrees of attenuation were 
almost dose dependent especially with the two higher doses. AGE exhibits a dose-dependent 
ameliorative action on indicators of diabetes in STZ-induceddiabetic rats56. 
 
4.2.4 Wang J et.al (2016), evaluated the Antidiabetic and Antinephritic Activities of 
Paecilomyces hepiali Water Extract (PHC) in Diet-Streptozotocin-Induced Diabetic Sprague 
Dawley Rats. PHC promotes glucose metabolism by enhancing insulin, pyruvate kinase activity, 
and increasing the synthesis of glycogen. PHC normalized the disturbed levels of superoxide 
dismutase, methane dicarboxylic aldehyde, and glutathione peroxidase in kidney. The inhibitory 
effects on the levels of interleukin-2, interleukin-6, interleukin-10, and tumor necrosis factor-α 
in serum and kidney revealed the protection of PHC against diabetic nephropathy. Compared 
with nontreated diabetic rats, four-week PHC treatment resulted in a decrement on nuclear factor 
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kappa B expression in kidney. These results show that Paecilomyces hepiali possesses 
antidiabetic and antinephritic effects which are related to the modulation of nuclear factor kappa 
B activity57. 
 
4.2.5 Moodley K et.al (2015), Antioxidant, antidiabetic and hypolipidemic effects of 
Tulbaghia violacea Harv. (wild garlic) rhizome methanolic extract in a diabetic rat model. TVL 
treatment improved body weights, significantly reduced fasting blood glucose levels, improved 
glucose tolerance and significantly increased plasma insulin and liver glycogen content. TVL 
treatment also reduced liver thiobarbituric acid reactive substances (TBARS) levels, increased 
liver superoxide dismutase (SOD), catalase and glutathione peroxidase (GPx) and increased 
plasma nitric oxide (NO) levels. Furthermore, TVL administration reduced serum triglycerides, 
VLDL, total-cholesterol levels and increased HDL-cholesterol levels. TVL also reduced serum 
levels of liver enzymes, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) 
58. 
 
4.2.6 Babin D Reejo et.al (2014), evaluated the Antidiabetic Activity Of Samanea Saman 
(Jacq.) Merr. Methanolic extract of Samaneasaman(Jacq.) Merr. at the doses of 250 mg/kg p.o 
and 500mg/kg p.o significantly reduces the increased blood glucose level as compared to the 
disease control group (p<0.001) at1 and 2, (p<0.05) 1/2 hours respectively inepinephrine 
induced diabetic rats. Also shows significant α- amylase inhibition in concentrations such as 
50μ g/ml ˂ 100μ g/ml ˂ 150μ g/ml ˂ 200μg/ml˂250μ g/ml. Evaluation of active compounds from 
the methanolic extract of Samaneasaman(Jacq.) Merr. for their antidiabetic activities may paw 
the way for the identification of a new class of phytochemical for the treatment of diabetes 
mellitus 59. 
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5. SCOPE OF WORK 
Management of Diabetes mellitus is a global problem, successful treatment is very 
important for preventing or at least delaying the onset of long term diabetic complications like 
diabetic neuropathy, nephropathy, retinopathy, erectile dysfunction, hypertension and injury 
caused by ischaemic and reperfusion. Through nature in the form of herbal medicines or drugs 
with very minimal adverse effects are preferred when compared to the available synthetic drugs 
to treat such chronic disease and disorders. Herbal drugs as therapeutic agents are a nature’s 
boon when compared to the severe adverse effects of the allopathic medical practice for 
diabetes, despite the fact that the search for a complete and permanent cure for the disease is 
being pursued uncompromisingly by eluding physicians and researchers. These herbal 
remedies which exemplifies the process of symbiosis still remains unfamiliar up to data 
technical advances, which has fashioned a marvelous scope for folk lore or traditional 
medicines .It is supposed that the tradition medicines used for the treatment of diabetes mellitus 
satisfy the sequence of complication of the disease.  
Even though, the traditional medicinal plants are used to cure the disease from human 
origin, scientific validation of such medicinal plants are necessary and also a scientific research 
to prove its pharmacological and therapeutic efficacy is became vital.  
Nymphaea pubescens willd is having the anti-diabetic activity. As per the literature 
review still no anti-diabetic activity has been reported on this whole plant. Hence, this study 
has been taken to explore the anti-diabetic potential of Nymphaea pubescens willd on 
streptozotocin induced diabetes in wistar albino rats. 
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6. PLAN OF WORK 
1. Collection of Nymphaeae pubescens.  
2. Authentication of plant. 
3. Preparation of ethanolic extract of Nymphaeae pubescens. (EENP) 
4. Experimental Animals 
5. Preliminary Phytochemical screening  
6. Acute toxicity studies (OECD 423guidelines)  
7. Induction of diabetes mellitus in experimental animals 
8. Effect of EENP on blood glucose level on STZ induced diabetic rats for 21 days 
9. Effect of EENP on Serum glutamic oxaloacetic transaminase (SGOT) 
10. Effect of EENP on Serum glutamic pyruvic transaminase (SGPT) 
11. Effect of EENP on serum lipid profiles  
a. Total cholesterol in serum  
b. HDL-cholesterol in serum  
c. Triglycerides in serum  
d. Very low density lipoprotein (VLDL)  
e. Low density lipoprotein (LDL) 
12. Effect of EENP on serum biomarker profiles  
a. Serum total protein 
b. Serum creatinine 
13. Histopathology 
14. Statistical analysis by one way ANOVA followed by Dunnet’s test 
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7. Materials and Methods 
 
7.1 Collection of Plant Nymphaea Pubescesns:  
 
The whole plant of Nymphaea Pubescesns willd used for the present study was obtained 
from Nandivaram, Guduvancherry, Chennai, Tamil Nadu, India. 
 
7.2 Authentication of plant: 
 
The plant material was identified and authenticated by Dr.P.Jayaraman, Retd. 
Professor, Presidency College, Chennai–600005, Tamilnadu. [PARC/2017/3473]. A voucher 
specimen was submitted at C.L.Baid Metha College of Pharmacy, Chennai- 600097 
 
7.3 Sample Extraction:  
 
The sample was washed with distilled water to remove any adherent particles, shade 
dried and powdered. 25g of each sample was weighed and extracted with 300ml of ethanol by 
continuous hot percolation with the help of soxhlet apparatus for 10hrs of time. On completion 
the extract was filtered and concentrated using rotary evaporator under reduced pressure and 
controlled temperature of 500C – 600 C. The concentrates were stored in the refrigerator for 
further use. 
 
7.3.1 Percentage yield 
 
The percentage yield of hydro alcoholic extract was 6.84 % w/v and it was preserved 
in refrigeration for further use.  
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7.4 Chemicals 
 
All the Chemicals used in the study were of analytical grade. The following chemicals 
were used for the experimental study.  
   
Table1: Name of the chemicals and their source  
 
S.No Materials Sources 
1.  Absolute alcohol S.d.fine chemicals Ltd, Mumbai 
2.  Chloroform S.d.fine chemicals Ltd, Mumbai 
3.  Copper sulphate Qualigens fine chemicals, Mumbai 
4.  Creatinine kit Span diagnosis Ltd, Bangalore 
5.  DNS (3,5-dinitrosalicylic acid) Sigma chemical Co., USA 
6.  Ethanol S.d.fine chemicals Ltd, Mumbai 
7.  Glucose test strips One touch Horizon test strips 
8.  HDL kit Span diagnosis Ltd, Bangalore 
9.  Hydrochloric acid Qualigens fine chemicals, Mumbai 
10.  Hydrogen peroxide solution Qualigens fine chemicals, Mumbai 
11.  Sodium hydrogen carbonate S.d.fine chemicals Ltd, Mumbai 
12.  LDL kit Span diagnosis Ltd, Bangalore 
13.  Petroleum ether Sigma chemical Co., USA 
14.  p-nitrophenyl glucopyranoside S.d.fine chemicals Ltd, Mumbai 
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15.  Pyrogallol S.d.fine chemicals Ltd, Mumbai 
16.  SGOT kit Span diagnosis Ltd, Bangalore 
17.  SGPT kit Span diagnosis Ltd, Bangalore 
18.  Sodium hydroxide Qualigens fine chemicals, Mumbai 
19.  Total protein kit Span diagnosis Ltd, Bangalore 
20.  Total cholesterol kit Span diagnosis Ltd, Bangalore 
21.  Triglycerides kit Span diagnosis Ltd, Bangalore 
22.  Urea kit Span diagnosis Ltd, Bangalore 
23.  VLDL kit Span diagnosis Ltd, Bangalore 
 
7.5 Experimental design 
 
Adult Male Wistar rats of weighing 180-230 gms were used for this study. The inbred 
animals were procured from the animal house of C.L. Baid Metha College of Pharmacy, 
Thoripakkam, Chennai- 97. They were housed five per cage under standard laboratory 
conditions at a room temperature at 22±20 C with 12 hr light/dark cycle. The animals were 
acclimatized to laboratory conditions one week and provided with standard pellet chow and 
water ad libitum. Ethical committee clearance was obtained from IAEC of CPCSEA. 
(IAEC/L/07/CLBMCP/2017) 
 
7.6 Phytochemical analysis60 
 
7.6.1. TEST FOR TANNINS:  
 
1ml of sample was taken, to that few drops of 0.1 % ferric chloride was added and 
observed for brownish green or blue black coloration.  
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7.6.2. TEST FOR SAPONINS:  
 
1 ml of sample was taken, to that 2 ml of water was added .The suspension was shaken 
in a graduated cylinder for 15 minutes. A layer of foam indicates the presence of saponins.  
 
7.6.3. TEST FOR FLAVONOIDS:  
 
1 ml of sample was taken, to that few drops of Sodium hydroxide solution was added. 
Formation of intense yellow colour, which becomes colourless on further addition of diluted 
hydrochloric acid, indicated the presence of flavanoid  
 
7.6.4. TEST FOR ALKALOIDS:  
 
1 ml of sample was taken, to that few drops of dragandoff reagent was added. Prominent 
yellow precipitates indicate the test as positive.  
 
7.6.5. TEST FOR PROTEIN:  
 
1 ml of sample was taken, to that few drops of Millon’s reagent was added. A white 
precipitate indicates the presence of Protein.  
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7.6.6. TEST FOR STEROIDS:  
 
1 ml of sample was taken, to that two drops of concentrated sulphuric acid was added 
and observed for brown colour.  
 
7.6.7. TEST FOF ANTHRAQUINONES:  
 
1 ml of sample was taken, to that aqueous ammonia was added and observed for change 
in colour. Pink, red, or violet colour in aqueous layer indicates the presence of anthraquinoness.  
 
7.6.8. TEST FOR PHENOL:  
 
1 ml of sample was taken, to that 3 ml of 10% lead acetate solution is added a bulky 
white precipitate indicates the presence of phenolic compounds. 
 
7.7 Acute toxicity studies : 
Acute oral toxicity study was performed as per CPCSEA guidelines (acute toxic class 
method).The group of six animals were kept fasting for overnight and provided only with water, 
after which the extracts were administered orally at 5mg/kg body weight by gastric intubations 
and observed for 14 days. In case if the mortality was observed in two out of three animals, then 
the dose administered would be assigned as toxic dose. If mortality was observed in one animal, 
then the same dose would be repeated again to confirm the toxic dose. If mortality was not 
observed, the procedure would be repeated for higher doses such as 250, 500, 1000 and 2000 
mg/kg body weight61. 
 
7.7.1 Procedure: 
Adult male wistar albino rats weighed 180- 230gms were used for the study. The starting 
dose level of EENM Was 2000mg/kg body weight p.o. Most of the crude extracts possess LD50 
value more than 2000 mg/kg, p.o. so the starting dose which used was 2000mg/g p.o. Food was 
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withheld for a further 3-4 hrs after administration (p.o) of drugs and observed for the signs of 
toxicity.   
 Body weights of rats before and after administration were observed for morbidity and 
mortality. Any changes in skin, fur, eyes, mucous membrane, respiratory, circulatory, 
autonomic & central nervous system, motor activity and behaviour pattern were observed and 
also sign of tremors, convulsion, salivation, diarrhoea, lethargy, sleep and coma were noted.  
 
7.8.Induction of diabetes in experimental animals 
Animals were allowed to fast for 12 h and were administered freshly prepared 
streptozotocin (STZ) at the concentration of 55 mg/kg bodyweight, i.p. in 0.1 mol/L cold citrate 
buffer, pH 4.5. The STZ-treated animals were allowed to drink 5% glucose solution overnight 
to overcome drug-induced hypoglycemia. Rats which were having persistent glycosuria and 
hyperglycaemia with a fasting blood glucose >250 mg/dL on the third day after the STZ 
injection were considered diabetic and which were used for further experimentation62. 
 
7.9.Experimental Design 
The animals were divided into 5 groups each constituting 6 rats. Group I were normal 
rats received water, Group II were STZ (55 mg/kg b.w., i.p) induced diabetic rats which acts 
as diabetic control group. Group III STZ (55 mg/kg b.w., i.p) induced diabetic rats were treated 
with Glibenclamide 5mg/kg b.w/p.o Group IV STZ (55 mg/kg b.w., i.p) induced diabetic rats 
were treated with EENP 200mg/kg b.w/ p.o Group V STZ (55 mg/kg b.w., i.p) induced diabetic 
rats were treated with EENP 400mg/kg b w/p.o for 21 days63. 
 Fasting blood glucose levels was measured before the administration of extracts. The 
blood glucose levels were checked on 0th, 7th, 14th, and 21st day of the treatment period. Blood 
was collected from snipping of the rat tail. Blood glucose levels were measured by using the 
glucose oxidase peroxidase reactive strips and a glucometer (One touch glucometer). 
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7.10 Biochemical parameter studies: 
At the last day animal was sacrificed by decapitation, blood samples were collected and 
serum was separated using centrifuge to study the biochemical parameters. The estimation of 
protein was carried out using the method of Lowry64. The extraction of serum lipids were carried 
out by the method of Folch 65 and the serum cholesterol estimation was carried out by the method 
of Zlatkis66 Serum triglycerides were estimated by the method of Foster and Dunn and HDL 
cholesterol was estimated by the method of Burstein67. The VLDL cholesterol was evaluated 
using the formula, TG/5 mg/dl. The serum LDL cholesterol was estimated by the method of 
Friedwald68 SGOT and SGPT were measured by the method of Reitman and Frankel 
(Colorimetric method) 69 the plasma creatinine was measured by Jaffe’s method70 Serum urea 
was measured by the diacetyl monoxime method71 and Histopathology studies of liver and 
pancreas were carried out by using standard procedure. 
 
7.11 Histopathology 
At the end of the study, all the animals were sacrifices under light ether anesthesia. The 
rats were sacrificed by decapitation and blood samples were collected by bleeding of retro-
orbitol plexus using micro capillary technique from all the groups of overnight fasted rats and 
serum was separated to study the biochemical parameters. The relevant organs like pancreas, 
liver and kidney were removed and dissected out and washed with ice-cold saline. The organs 
were preserved in 10% formalin solution for histopathological studies. 
 
7.12 Statistical analysis 
The data were expressed as mean ± standard error (SEM). The significance of 
differences among the groups was assessed using one way analysis of variance (ANOVA). The 
test followed by Dunnet’s test p values lees than 0.05 were considered as significance.  
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8.1 Preliminary Phytochemical analysis of Ethanolic extract of Nymphaea pubescens willd 
(EENP) 
 The result of preliminary phytochemical analysis of Ethanolic extract of Nymphaea 
pubescens willd (EENP) showed presence of various phytochemical constituents such as, 
flavonoids, alkaloids, tannins, proteins, steroids and phenol with absence of saponins and 
anthroquinones. The results were shown in Table-1 
8.2 Acute Oral Toxicity Study: 
Acute oral toxicity study was performed as per CPCSEA guidelines (acute toxic class 
method).The group of six animals were kept fasting for overnight and provided only with water, 
after which the extracts were administered orally at 2mg/kg body weight by gastric intubations 
and observed for 14 days. If mortality was observed in two out of three animals, then the dose 
administered was assigned as toxic dose. If mortality was observed in one animal, then the same 
dose was repeated again to confirm the toxic dose. If mortality was not observed, the procedure 
was repeated for higher doses such as 250, 500, 1000 and 2000 mg/kg body weight. . The results 
were shown in Table-2 
 
8.3 Effect of EENP on body weight of STZ induced diabetic rats 
-It was found that the body weight was decreased significantly (p<0.001) when the 
comparison was made between group I with group II, group III, group IV and group V.  
-The bodyweight in group II was compared with group III, group IV and group V were 
increased significantly (p<0.001). The results were shown in (Table-3) (Histogram-1) 
 
8.4 Effect of EENP on blood glucose level of STZ induced diabetic rats 
 
- The blood glucose levels were compared between group I with group II, group III, 
group IV and group V and it was found that blood glucose levels were significantly increased 
(p<0.001).  
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-The blood glucose levels in group II was compared with group III, group IV and group 
V were significantly (p<0.001) decreased. The results were shown in (Table-4) (Histogram-2) 
 
8.5 Effect of EENP on serum cholesterol level of STZ induced diabetic rats 
 
- The serum cholestrol levels were compared between group I with group II, group III, 
group IV and group V and it was found that serum cholesterol levels were significantly increased 
(p<0.001).  
-The serum creatinine level in group II was compared with group III, group IV and group 
V were decreased significantly (p<0.001). The results were shown in (Table-5) (Histogram-3) 
 
8.6 Effect of EENP on serum triglyceride level of STZ induced diabetic rats 
 
- The serum triglycerides levels were compared between group I with group II, group 
III, group IV and group V and it was found that serum triglycerides levels were significantly 
increased (p<0.001).  
-The serum triglyceride level in group II was compared with group III, group IV and 
group V (p<0.001) were decreased significantly. The results were shown in (Table-5) 
(Histogram-4). 
 
8.7 Effect of EENP on serum HDL level of STZ induced diabetic rats 
 
- The serum HDL levels were compared between group I with group II, group III, group 
IV and group V and it was found that serum HDL levels were significantly decreased (p<0.001).  
- The HDL level in group II was compared with group III group IV and group V 
(p<0.001) increased significantly. The results were shown in (Table-5) (Histogram-5). 
 
8.8 Effect of EENP on serum LDL level of STZ induced diabetic rats 
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 - The serum LDL levels were compared between group I with group II, group III, group 
IV and group V and it was found that serum LDL levels were significantly increased (p<0.001). 
-The serum LDL level in group II was compared with group III group IV and group V 
(p<0.001) were significantly decreased. The results were shown in (Table-5) (Histogram-6). 
 
8.9 Effect of EENP on serum VLDL level of STZ induced diabetic rats 
 - The serum VLDL levels were compared between group I with group II, group III, 
group IV and group V and it was found that serum VLDL levels were significantly increased 
(p<0.001). 
-The serum VLDL level in group II was compared with group III, group IV and group 
V were significantly decreased (p<0.001). The results were shown in (Table-5) (Histogram-7). 
 
8.10 Effect of EENP on serum total protein level of STZ induced diabetic rats 
 
-The serum total protein level in group I was compared with group II (p<0.01), group III 
(ns), group IV (ns) and group V (ns) were increased significantly.  
-The serum total protein level in group II was compared with group III, (0.001) group 
IV and group V (p<0.01) were decreased significantly. The results were shown in (Table-6) 
(Histogram-8). 
 
8.11 Effect of EENP on serum creatinine level of STZ induced diabetic rats 
 
-The serum creatinine level in group I was compared with group II group III group IV 
and group V (p<0.001) and it was found that the levels were increased significantly.  
-The serum creatinine level in group II was compared with group III, group IV and group 
V (p<0.001) were decreased significantly. The results were shown in (Table-7) (Histogram-9). 
 
8.13 Effect of EENP on SGOT level of STZ induced diabetic rats 
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-The SGOT level in group I was compared with group II group III group IV and group 
V (p<0.001) and it was found that the levels were increased significantly.  
-The SGOT level in group II was compared with group III, group IV and group V were 
decreased significantly (p<0.001). The results were shown in (Table-8) (Histogram-10). 
 
8.14 Effect of EENP on SGPT level of STZ induced diabetic rats 
 
-The SGPT level in group I was compared with group II group III group IV and group 
V (p<0.001) and it was found that the levels were increased significantly.  
-The SGPT level in group II was compared with group III, group IV and group V were 
decreased significantly (p<0.001). The results were shown in (Table-9) (Histogram-11). 
 
8.15 Histopathology 
 
8.15.1 Histopathology of pancreas 
The histopathology of rat pancreas of control groups showed normal acini and islets 
whereas diabetic control groups showed damaged and atrophy islets with acini. Diabetic animal 
treated with glibenclamide (5mg/kg b.w/p.o) has showed preserved normal islets in pancreas, 
whereas EENP 200mg/kg/p.o treated animals has showed small pancreatic islet and EENP 
400mg/kg/p.o treated animals showed hyperplastic. 
8.15.2 Histopathology of Liver 
Histopathological examinations of diabetic animals showed centrilobular necrosis 
accompanied by fatty changes and ballooning degeneration which were observed in the 
remaining hepatocytes in the liver of rats treated with STZ (55mg/kg b.w/p.o) were much of 
intensity and which were recovered with the treatments using EENP.  
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9. Tables and figures 
Table- 1. Phytochemical screening of EENM 
 
Table-2. Acute oral toxicity studies of EENM (OECD 423 guideline) 
Si. 
No. 
 
Treatment 
group 
 
Dose 
Weight of animal 
in gms Signs of 
toxicity 
Onset of 
toxicity 
Reversible  
or 
irreversible 
Duration 
Before 
test 
After 
test 
1. EENM 2g/kg 200 210 
No signs of 
toxicity 
Nil Nil 14 days 
2. EENM 2g/kg 180 195 
No signs of 
toxicity 
Nil Nil 14 days 
 
3. 
EENM 24g/kg 190 200 
No signs of 
toxicity 
Nil Nil 14 days 
 
Table: The Phytochemical studies of the 
sample TEST 
Sample 
TANNINS + 
SAPONINS - 
FLAVONOIDS + 
ALKALOIDS 
 
+ 
PROTEINS + 
STEROIDS + 
ANTHROQUINONES - 
PHENOL + 
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Table-3. Effect of EENM on body weight of STZ induced diabetic rats 
Group Body weight (gm) 
Day – 0 Day – 7 Day – 14 Day – 21 
I 
185.2±1.930 184.2±2.271 194.5±0.7548 202.3±1.173 
II 
182.2±4.010 
151.5±1.482 
a*** 
134.5±1.988 
a*** 
125.7±0.892 
a*** 
III 182.34±2.186 171.2±2.012 
a***b*** 
172.5±1.222 
a***b*** 
180.0±1.780 
a***b*** 
IV 
182.12±3.615 
161.7±2.236
 
a***b
ns
 
162.8±0.9458 
a***b*** 
167.2±0.938 
a***b*** 
V 
184.8±3.137 
167.3±1.914 
a***b*** 
169.8±0.9098 
a***b*** 
173.8±1.337 
a***b*** 
 
 Values are expressed as mean ± SEM of 6 animals. 
Comparisons were made between the following: 
 a - Group I vs. II,III,IV and V, b - Group II vs.III, IV, and V.  
 Statistical Significance test for comparison was done by one way ANOVA followed by 
Dunnets ‘t’ test. Where *p< 0.05, **p< 0.01, ***P<0.001, ns-non significant. 
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Histogram-1. Effect of EENM on body weight 
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Table-4. Effect of EENM on blood glucose level in STZ induced diabetic 
rats 
Group Blood glucose (mg/dl) 
Day – 0 Day – 7 Day – 14 Day – 21 
I 91.35±3.130 93.50±1.660 95.83±3.646 91.33±2.996 
II 
100.178±4.649 
249.07±1.922a
a*** 
284.2±2.110 
a*** 
290.7±1.510 
a*** 
III 
104.216±5.890 
171.01±1.549 
a***b*** 
141.89±1.461
a*** b*** 
122.795±1.783 
a*** b*** 
IV 98.03±6.260 219.159±1.497 
a***b*** 
202.53±2.057 
a***b*** 
160.7±1.515 
a***b*** 
V 92.131±3.170 181.371±1.438 
a***b*** 
161.26±1.316 
a***b*** 
121.049±1.150 
a**b*** 
 
 Values are expressed as mean ± SEM of 6 animals. 
Comparisons were made between the following: 
 a - Group I vs. II,III,IV and V, b - Group II vs.III, IV, and V.  
 Statistical Significance test for comparison was done by one way ANOVA followed by 
Dunnets ‘t’ test. Where *p< 0.05, **p< 0.01, ***P<0.001, ns-non significant. 
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Histogram-2. Effect of EENM on blood glucose 
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Table-5.Effect of EENM on total cholesterol, Triglycerides, HDL, LDL, 
VLDL 
 
 Values are expressed as mean ± SEM of 6 animals. 
Comparisons were made between the following: 
 a - Group I vs. II,III,IV and V, b - Group II vs.III, IV, and V.  
 Statistical Significance test for comparison was done by one way ANOVA followed by 
Dunnets ‘t’ test. Where *p< 0.05, **p< 0.01, ***P<0.001, ns-non significant. 
 
   
Group
s 
Treatment Total 
cholesterol 
(mg/dl) 
Triglycerid
es 
(mg/dl) 
HDL 
(mg/dl) 
LDL 
(mg/dl) 
VLDL 
(mg/dl) 
I Control 106.3±0.352 86.4±0.38 61.03±0.3
7 
41.4±0.48 18.69±0.4
9 
II Diabetic 
control 
55mg stz 
207.6±0.319 
a*** 
170.2±0.44 
a*** 
34.56±0.4
6 
a*** 
139.43±0.7
4 
a*** 
40.17±0.6
1 
a*** 
III STZ+ 
Glibenclami
de 
120.7±0.576 
a***b*** 
92.1±0.49 
a***b*** 
56.71±0.6
9 
a**b*** 
86.59±0.42 
a**b*** 
26.69±0.3
7 
a***b*** 
IV STZ+EENM 
200 mg 
159.83±0.29 
a***b*** 
129.4±0.29 
a***b*** 
42.03±0.3
7 
a***b*** 
113.21±0.4
9 
a***b*** 
30.46±0.2
9 
a***b*** 
V STZ+EENM 
400 mg 
137.783±0.3
90 
a***b*** 
100.1±0.18 
a***b*** 
53.21±0.5
3 
a***b*** 
92.84±0.51 
a***b*** 
24.84±0.2
4 
a***b*** 
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 Histogram-3. Effect of EENM on Total cholestrol 
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Histogram-4. Effect of EENM on Triglycerides 
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 Histogram-5. Effect of EENM on HDL 
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Histogram-6. Effect of EENM on LDL 
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Histogram-7. Effect of EENM on VLDL 
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Table-6. Effect of EENM on Total protein in STZ induced diabetic rats 
Groups Treatment Total protein (mg/dl) 
I Control 6.38±0.1767 
II STZ (55mg/kg b.w., i.p) induced diabetic rats 5.24±0.1344 a** 
III STZ (55mg/kg b.w., i.p) induced diabetic rats 
treated with glibenclamide (5mg/kg b.w., p.o) 
6.48±0.1186 
ans b***  
IV STZ (55mg/kg b.w., i.p) induced diabetic rats 
treated with EENM (200mg/kg b.w., p.o) 
6.23±0.1271 
ans b** 
V STZ (55mg/kg b.w., i.p) induced diabetic rats 
treated with EENM (400mg/kg b.w., p.o) 
6.33±0.1308 
ans b** 
 
 Values are expressed as mean ± SEM of 6 animals. 
Comparisons were made between the following: 
 a - Group I vs. II,III,IV and V, b - Group II vs.III, IV, and V.  
 Statistical Significance test for comparison was done by one way ANOVA followed by 
Dunnets ‘t’ test. Where *p< 0.05, **p< 0.01, ***P<0.001, ns-non significant. 
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Histogram-8. Effect of EENM on Total Protein 
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Table-7. Effect of EENM on Creatinine in STZ induced diabetic rats 
Groups Treatment Creatinine (mg/dl) 
I Control 0.47±0.0281  
II STZ (55mg/kg b.w., i.p) induced diabetic rats 1.72±0.0277 a*** 
III STZ (55mg/kg b.w., i.p) induced diabetic rats 
treated with glibenclamide (5mg/kg b.w., p.o) 
0.62±0.0185 a***b*** 
IV STZ (55mg/kg b.w., i.p) induced diabetic rats 
treated with EENM (200mg/kg b.w., p.o) 
1.34±0.0296 a***b*** 
V STZ (55mg/kg b.w., i.p) induced diabetic rats 
treated with EENM (400mg/kg b.w., p.o) 
0.89±0.0170 a***b*** 
 
 Values are expressed as mean ± SEM of 6 animals. 
Comparisons were made between the following: 
 a - Group I vs. II,III,IV and V, b - Group II vs.III, IV, and V.  
 Statistical Significance test for comparison was done by one way ANOVA followed by 
Dunnets ‘t’ test. Where *p< 0.05, **p< 0.01, ***P<0.001, ns-non significant. 
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Histogram-9. Effect of EENM on Creatinine 
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Table-8. Effect of EENM on SGOT in liver tissue of STZ induced diabetic rats 
Groups Treatment SGOT (U/L) 
I Control 47.01±0.12 
II STZ (55mg/kg b.w., i.p) induced diabetic rats 115.03±0.64  
a*** 
III STZ (55mg/kg b.w., i.p) induced diabetic rats 
treated with glibenclamide (5mg/kg b.w., p.o) 
45.86±0.58  
a***b*** 
IV STZ (55mg/kg b.w., i.p) induced diabetic rats 
treated with EENM (200mg/kg b.w., p.o) 
66.83±0.29  
a***b*** 
V STZ (55mg/kg b.w., i.p) induced diabetic rats 
treated with EENM (400mg/kg b.w., p.o) 
55.86±0.36  
a***b*** 
 
 Values are expressed as mean ± SEM of 6 animals. 
Comparisons were made between the following: 
 a - Group I vs. II,III,IV and V, b - Group II vs.III, IV, and V.  
 Statistical Significance test for comparison was done by one way ANOVA followed by 
Dunnets ‘t’ test. Where *p< 0.05, **p< 0.01, ***P<0.001, ns-non significant. 
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Histogram-10. Effect of EENM on SGOT 
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Table-9. Effect of EENM on SGPT in liver tissue of STZ induced diabetic 
rats 
Groups Treatment SGPT (U/L) 
I Control 24.01±0.12 
II STZ (55mg/kg b.w., i.p) induced diabetic rats 50.29±0.54  
a*** 
III STZ (55mg/kg b.w., i.p) induced diabetic rats 
treated with glibenclamide (5mg/kg b.w., p.o) 
28.86±0.58  
a***b*** 
IV STZ (55mg/kg b.w., i.p) induced diabetic rats 
treated with EENM (200mg/kg b.w., p.o) 
40.13±0.89  
a***b*** 
V STZ (55mg/kg b.w., i.p) induced diabetic rats 
treated with EENM (400mg/kg b.w., p.o) 
32.86±0.66  
a***b*** 
 
 Values are expressed as mean ± SEM of 6 animals. 
Comparisons were made between the following: 
 a - Group I vs. II,III,IV and V, b - Group II vs.III, IV, and V.  
 Statistical Significance test for comparison was done by one way ANOVA followed by 
Dunnets ‘t’ test. Where *p< 0.05, **p< 0.01, ***P<0.001, ns-non significant. 
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Histogram-11. Effect of EENM on SGPT 
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HISTOPATHOLOGICAL ANALYSIS OF PANCREAS 
 
 
Histopathology of Pancreas- Group-I 
 
 
 
 
Histopathology of Pancreas- Group-II 
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Histopathology of Pancreas- Group-III 
 
 
 
 
Histopathology of Pancreas- Group-IV 
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Histopathology of Pancreas- Group-V 
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HISTOPATHOLOGICAL ANALYSIS OF LIVER 
 
 
Histopathology of Liver- Group-I 
 
 
 
Histopathology of Liver- Group-II 
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Histopathology of Liver- Group-III 
 
 
 
 
Histopathology of Liver- Group-IV 
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Histopathology of Liver- Group-V 
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10. DISCUSSION & CONCLUSION  
10.1 Discussion 
 The ethanolic extract from whole plant of Nymphaea Pubescens were subjected to 
preliminary phytochemical analysis which shown presence of flavonoids, alkaloids, tannins, 
proteins, steroids and phenol with absence of saponins and anthroquinones. 
 Acute oral toxicity studies of EENP did not produce any mortality or signs of toxicity at 
the dose of 2000 mg/kg b.w/p.o, in experimental rats. 
The anti-hyperglycemic effects of the plants is due to their ability to restore the function 
of pancreatic tissues by causing an increase in insulin output or inhibit the intestinal absorption 
of glucose or to the facilitation of metabolites in insulin dependent processes. Hence, treatment 
with herbal drugs has an effect on protecting b cells and smoothing out fluctuation in glucose 
levels72 The present study evalulation of anti-diabetic activity of whole plant of Nymphaea 
pubescens STZ induced diabetic rats. 
Experimental induction of hyperglycemia with STZ is associated with the characteristic 
loss of body weight which is due to loss or degradation of structural proteins it leads to increased 
muscle wasting and due to loss of tissue protein, as the structural proteins are known to 
contribute to body weight. Diabetic rats treated with glibenclamide and EENP showed increased 
body weight when compared to untreated diabetic animals. It may be due to increased insulin 
secretion and glycemic control of EENP. 
Reduced glucose transport or absorption from the gut, extra pancreatic action probably 
by stimulation of glucose utilization in peripheral tissues, increase in glycogenic or glycolytic 
enzyme activities in peripheral tissues, decrease in the secretion of counter-regulatory hormones 
like glucagon, growth hormones are the possible mechanisms involved with suppressing blood 
glucose levels. The glibenclamide, stimulating insulin secretion from pancreatic β cells 
principally by inhibiting ATP sensitive KATP channels in the plasma membrane and decreases 
the blood glucose level73. Blood glucose level decreased significantly in glibenclamide and 
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EENP treated diabetic rats and the histopathology of pancreas showed normal islets in pancreas 
with normal anatomy compared with normal rats which may be due to the anti-diabetic activity. 
Hyperglycaemia is accompanied with dyslipidemia under normal circumstances; insulin 
activates the enzyme lipoprotein lipase, which hydrolyses triglycerides. However, in diabetic 
state lipoprotein lipase is not activated due to insulin deficiency, resulting in hyper 
triglyceridemia, and insulin deficiency is also associated with hyper cholesterolemia due to 
metabolic abnormalities. The dyslipidemia is characterized by increase in TC, LDL, VLDL, TG 
and fall in HDL which is observed in STZ induced diabetic rats74. The diabetic rats treated with 
glibenclamide and EENP showed reduced severity of dyslipidemia with decrease in TC, LDL, 
VLDL, TG and increase in HDL. 
Both SGOT and SGPT enzyme levels get elevated during liver damage which is more 
in diabetic rats75. The diabetic rats treated with glibenclamide and EENP reduced the SGOT and 
SGPT level. The liver histopathology of STZ induced diabetic rats showed centrilobular 
necrosis accompanied by fatty changes and ballooning degeneration in the hepatocytes 
treatment with EENP reversed in diabetic rats treated with glibenclamide and EENP which 
indicates that the liver damage is reduced in EENP treated group. 
The diabetic hyperglycaemia induces elevation of the serum levels of creatinine which 
are significant markers of renal dysfunction, The treatment of EENP in rats showed marked 
decrease in serum creatinine levels in diabetic animals. 
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10.2 Conclusion 
The anti-diabetic activity of Whole pant of Nymphaea pubescens Willd is evidenced by 
blood glucose level, estimation of lipid profile activity of Nymphaea pubescens and the evident 
reduction in SGOT, SGPT in liver and creatinine in serum also proves that the Nymphaea 
pubescens reduced the Pancreas, liver damage which is common in diabetes. 
Thus, it may be concluded that Nymphaea pubescens produced significant antidiabetic 
activity in streptozotocin induced diabetic rats. The efficacy of the Nymphaea pubescens was 
comparable to that of Glibenclamide. Further work was necessary to elucidate the mechanism 
of action involved in the anti-diabetic activity of Nymphaea pubescens with special references 
to phytochemicals. 
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